[go: up one dir, main page]

DE60041363D1 - Präparierung von sphären für diagnostische tests - Google Patents

Präparierung von sphären für diagnostische tests

Info

Publication number
DE60041363D1
DE60041363D1 DE60041363T DE60041363T DE60041363D1 DE 60041363 D1 DE60041363 D1 DE 60041363D1 DE 60041363 T DE60041363 T DE 60041363T DE 60041363 T DE60041363 T DE 60041363T DE 60041363 D1 DE60041363 D1 DE 60041363D1
Authority
DE
Germany
Prior art keywords
sphere
preparation
diagnostic tests
surfactant
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041363T
Other languages
English (en)
Inventor
Susan Goertz
Paul Hemmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spectral Diagnostics Inc Canada
Original Assignee
Spectral Diagnostics Inc Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectral Diagnostics Inc Canada filed Critical Spectral Diagnostics Inc Canada
Application granted granted Critical
Publication of DE60041363D1 publication Critical patent/DE60041363D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60041363T 1999-07-14 2000-07-14 Präparierung von sphären für diagnostische tests Expired - Lifetime DE60041363D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35319199A 1999-07-14 1999-07-14
US61601800A 2000-07-13 2000-07-13
PCT/IB2000/000967 WO2001004633A2 (en) 1999-07-14 2000-07-14 Preparation of spheres for diagnostic tests

Publications (1)

Publication Number Publication Date
DE60041363D1 true DE60041363D1 (de) 2009-02-26

Family

ID=26997838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041363T Expired - Lifetime DE60041363D1 (de) 1999-07-14 2000-07-14 Präparierung von sphären für diagnostische tests

Country Status (9)

Country Link
US (2) US7256000B2 (de)
EP (1) EP1336107B1 (de)
JP (1) JP4536304B2 (de)
AT (1) ATE420365T1 (de)
AU (1) AU6008800A (de)
CA (1) CA2378742C (de)
DE (1) DE60041363D1 (de)
ES (1) ES2322931T3 (de)
WO (1) WO2001004633A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006330913B2 (en) * 2005-12-21 2011-10-27 Meso Scale Technologies, Llc Assay modules having assay reagents and methods of making and using same
KR101423938B1 (ko) 2005-12-21 2014-08-06 메소 스케일 테크놀러지즈, 엘엘시 분석 장치, 방법 및 시약
US7704702B2 (en) * 2006-08-10 2010-04-27 Inverness Medical Switzerland Gmbh Test strip for lateral flow assays
EP2171453A4 (de) * 2007-06-29 2010-10-06 Correlogic Systems Inc Ovarialkarzinom-vorhersagemarker
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
US9354144B2 (en) * 2011-09-20 2016-05-31 Bio-Rad Laboratories, Inc. Customized quality controls for analytical assays
KR101280054B1 (ko) * 2012-05-31 2013-06-28 에스디 바이오센서 주식회사 현장진단 면역크로마토그래피용 동결건조 접합체 구조물, 이를 이용하는 면역분석용 키트 및 상기 키트를 이용하는 분석방법
CN102809651B (zh) * 2012-07-26 2015-07-15 博奥赛斯（天津）生物科技有限公司 肌酸磷酸激酶同工酶化学发光免疫定量检测试剂盒及其制备方法
US11647993B2 (en) * 2017-12-22 2023-05-16 Research Triangle Institute Oral fluid collector
LU100795B1 (en) * 2018-05-14 2019-11-14 Diatron MI PLC Immunoassay for whole blood samples
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
US3932943A (en) 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
US4115537A (en) 1976-09-07 1978-09-19 American Hospital Supply Corporation Resin tablet and use thereof in diagnostic tests
WO1987000196A1 (en) * 1985-07-09 1987-01-15 Quadrant Bioresources Limited Protection of proteins and the like
US4655047A (en) 1985-03-25 1987-04-07 I.Q.F. Inc. Process for freezing or chilling
US4820627A (en) 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
WO1989009402A1 (en) * 1988-03-30 1989-10-05 Toray Industries, Inc. FREEZE-DRIED COMPOSITION CONTAINING ENZYME-LABELED ANTIHUMAN INTERFERON-beta ANTIBODY AND ENZYMATIC IMMUNOASSAY KIT CONTAINING THE COMPOSITION
US4848094A (en) 1988-04-29 1989-07-18 Union Carbide Corporation Droplet freezing method and apparatus
AU609332B2 (en) * 1988-11-09 1991-04-26 Biotrack, Inc. Method and composition of stabilizing and solubilizing latex reagents
EP0410207B1 (de) 1989-07-24 1997-01-22 Bayer Corporation Stabilisierung von hochgereinigten Proteinen
US5413732A (en) * 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5776563A (en) 1991-08-19 1998-07-07 Abaxis, Inc. Dried chemical compositions
DE69220080T2 (de) * 1991-10-11 1997-12-11 Abbott Lab Reagenzzusammensetzung in form von benutzer-einheiten für spezifische bindungstests
JPH07287008A (ja) * 1994-04-18 1995-10-31 Taisho Pharmaceut Co Ltd 炎症性疾患治療薬の簡易試験法
US5804370A (en) 1994-06-08 1998-09-08 Critichem Medical Products Limited Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
JPH0966401A (ja) 1995-06-21 1997-03-11 Canon Inc 円筒部材およびその製造方法ならびに製造装置
JP3624543B2 (ja) * 1996-05-02 2005-03-02 東ソー株式会社 免疫反応試薬及びその製造方法
BR9800655A (pt) * 1997-04-21 1999-08-10 Randox Lab Ltd Dispositivo de estado sólido para efetuar ensaios com múltiplos analisados seu uso e e sistema para análise de múltiplos analisados

Also Published As

Publication number Publication date
EP1336107B1 (de) 2009-01-07
US7498028B2 (en) 2009-03-03
US20030059766A1 (en) 2003-03-27
US7256000B2 (en) 2007-08-14
CA2378742A1 (en) 2001-01-18
CA2378742C (en) 2010-06-01
WO2001004633A3 (en) 2003-05-30
WO2001004633A2 (en) 2001-01-18
ATE420365T1 (de) 2009-01-15
ES2322931T3 (es) 2009-07-02
AU6008800A (en) 2001-01-30
US20070269839A1 (en) 2007-11-22
JP4536304B2 (ja) 2010-09-01
EP1336107A2 (de) 2003-08-20
JP2003527566A (ja) 2003-09-16

Similar Documents

Publication Publication Date Title
BR9815289A (pt) Imunoglobulina modificada, molécula, ácidonucleico isolado, célula contendo o mesmo, animalnão-humano recombinante, composiçãofarmacêutica, composição de vacina, processospara identificar ou medir ou detectar um antìgenode câncer, um antìgeno de um agente de doençainfecciosa, um ligante, e um receptor em umaamostra a ser testada, kits para detecção de umantìgeno de câncer, de um antìgeno de um agentede doença infecciosa, de um receptor celular paraum agente de doença infecciosa, de um ligante, e deum antìgeno de câncer, processos de diagnósticoou de exame para a presença de ou umapredisposição para desenvolvimento de um câncertipificado pela presença aumentada de umantìgeno de câncer, e para a presença de umagente de doença infecciosa, processos detratamento ou de prevenção de um câncertipificado pela presença de um antìgeno de câncer,de uma doença infecciosa tipificada pela presençade um antìgeno de agente de doença infecciosa, ede uma doença causada por um agente de doençainfecciosa que se liga em um receptor celular,processos para modulação de atividade de umprimeiro membro de um par de ligação, processo deprodução de uma imunoglobulina modificada,processo de produção de um ácido nucleicocodificador de imunoglobulina modificada, e, ácidonucleico isolado
DK1322960T4 (da) Allergen-mikroarrayassay
FI2645106T4 (fi) Menetelmiä terapeuttisen aineen aikaansaaman immuunivasteen arvioimiseksi
DE602005015894D1 (de) Diagnostische testvorrichtung
DE60041363D1 (de) Präparierung von sphären für diagnostische tests
GB2393512A (en) Use of a biochip for the diagnosis of sepsis or sepsis related syndrome
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
BR0113213A (pt) Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ATE412179T1 (de) Nachweis von arzneistoffen der methamphetamingruppe
WO2002063271A3 (en) Activity based probe analysis
DE60044420D1 (de) Enzym-Protein-Komplex
WO2003106649A3 (en) CONJUGATE TEST AND USES THEREOF
BRPI0416270A (pt) método para detectar um analito em uma amostra, e, método e kit para detectar um anticorpo especìfico de uma amostra
BR9507389A (pt) Método para detectar a presença de uma espécie mycobacterium e um kit e anticorpos para uso no mesmo
FI20012603A0 (fi) Diagnostinen menetelmä
Nibbeling et al. Use of monoclonal antibodies prepared against Schistosoma mansoni hatching fluid antigens for demonstration of Schistosoma haematobium circulating egg antigens in urine.
ATE292283T1 (de) Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
WO2001088538A3 (en) Compositions and methods for epitope mapping
ES2093601T3 (es) Inmunoensayo de polarizacion de fluorescencia para tetrahidrocannabinoides.
NZ512332A (en) Potassium channel interactors and uses therefor
FR2841988B1 (fr) Methode de diagnostic serologique comprenant un controle positif de l'introduction d'un serum humain a tester
DE58907725D1 (de) Mittel für immunchemische Tests enthaltend Aminoxide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition